ѻý

Vraylar Competition; 'Safer Gambling' Blunder; Ukraine Psych Hospital Invaded

<ѻý class="mpt-content-deck">— News and commentary from the psychiatry world
MedpageToday
Illustration of a brain shaped maze.

Compared with monotherapy, for 16 weeks significantly improved Positive and Negative Syndrome Scale total score in patients with schizophrenia -- but they also saw many more side effects like weight gain and sexual dysfunction. (Lancet Psychiatry)

According to GlobalData, will have to compete with low-cost aripiprazole and quetiapine generics if approved for adjunctive treatment of major depressive disorder. Developer AbbVie for this indication to the FDA last month.

Combination treatment of 1.0-mg twice daily plus a nicotine patch significantly improved smoking cessation among smokers who also drink heavily, according to a randomized clinical trial of 122 people. (JAMA Network Open)

A was released from Guantanamo Bay and sent home to Saudi Arabia for mental health care for schizophrenia. (New York Times)

Novamind announced it is moving forward with a phase II clinical trial testing .

An online casino in the U.K. was fined over £1 million after sending free spins to during the annual "Safer Gambling Week." (The Guardian)

announced it broke ground on a $72-million, 150-bed psychiatric hospital. (Masslive.com)

A with 670 people inside -- many of whom "have been bedridden for years" -- was taken over by Russian forces. (Reuters)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.